Tempe, Ariz., April 8, 2021 – Arizona State University, through Skysong Innovations, continues to achieve high rankings in technology transfer metrics. The latest read on this is a survey by the Association of University Technology Managers (AUTM). According to AUTM’s most recent survey (fiscal year 2019), ASU was fourth in patents granted, fourth in startups companies launched and third in inventions disclosed when compared to other universities without a medical school.
Author Archive: AZBioPEERS Team
Life365 Continues to Build Upon Its Hospital@Home Product Offering with Eat Fit Go Partnership
SCOTTSDALE, AZ, April 6, 2021— Life365, a leading virtual care platform provider, announced its partnership with EAT FIT GO Wellness, a healthy lifestyles company that empowers wellbeing from the inside out with premium, convenient and healthy nutrition. EAT FIT GO specializes in ready to heat and serve healthy prepackaged meals designed to be affordable, convenient and nutritious.
NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins
Early-stage trial to evaluate safety and immunogenicity.
In investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate’s safety and immunogenicity in adult volunteers. The vaccine, known as mRNA-1273.351, was developed by the biotechnology company ModernaTX, Inc., based in Cambridge, Massachusetts. The trial is led and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial will enroll approximately 210 healthy adult volunteers at four clinical research sites in the United States that are part of the NIAID-funded Infectious Diseases Clinical Research Consortium(IDCRC).
BD Announces FDA Emergency Use Authorization for Combination COVID-19, Flu Rapid Antigen Test
FRANKLIN LAKES, N.J., March 30, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for a new, rapid antigen test that can detect SARS-CoV-2, influenza A and influenza B in a single test.
Mayo Clinic and ASU MedTech Accelerator boosts health startups
The partnership propels a new cohort of next-generation medical technology and service startups forward with one-of-a-kind tools and resources.
Few things have better illustrated the need for innovative medical technologies than the COVID-19 pandemic. The Mayo Clinic and ASU MedTech Accelerator, a flagship program of the Mayo Clinic and ASU Alliance for Health Care, was designed to help empower medical startups to better navigate challenges while bringing forth life-changing health innovations. The second cohort of this program is set to launch March 30, 2021.
Life365 Adds AliveCor’s Personal EKG Technology to their Virtual Care Platform
SCOTTSDALE, AZ, March 30, 2021— Life365, a leading virtual care platform provider, announced its integration of products from AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, to enhance their remote cardiac monitoring solutions for healthcare consumers and patients located outside traditional care settings.
Equine Amnio Solutions Signs Exclusive Agreement For Distribution Of RenoVō®, A Next-Generation Equine Regenerative Product
ARGYLE, Texas, March 25, 2021 /PRNewswire/ — Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today that Covetrus, a global leader in animal-health technology and services, will be the exclusive distributor of the RenoVō® equine allograft throughout the United States.
First cases of South African COVID-19 variant detected in Arizona
PHOENIX — The Arizona Department of Health Services (ADHS), Maricopa County Department of Public Health, and Translational Genomics Research Institute (TGen) reported today that the B.1.351 COVID-19 variant strain, commonly referred to as the South African variant, has been confirmed in two test samples from the state.
CND Life Sciences Closes Series Seed Funding Round
Innovators of the Syn-One Test™ Building Market Presence and Infrastructure
PHOENIX, AZ — March 23, 2021 — CND Life Sciences, Inc. (https://cndlifesciences.com/), an innovative medical technology company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, announced today the closing of a $2.4 million series seed financing round. HonorHealth, a local health system serving 1.6 million people in the greater Phoenix area, joined several experienced financial investors in funding the round.
New Study Analyzes Potential Impact of Various Drug Pricing Proposals
The Council of State Bioscience Associations (CSBA) today, released data analyzing the potential impact of various drug pricing proposals on patient access to lifesaving medicines, future biomedical innovation, and the economic health of the life sciences industry.
The study, which was conducted by Vital Transformation, an international health economics firm, examines the negative effects of bills like “Lower Drug Costs Now Act of 2019” and other foreign reference pricing models had they been enacted.